ESC 365 - Echocardiography machine learning based to improve detection of transthyretin cardiac amyloidosis: the R3M algorithm

HFA Premium Access

Echocardiography machine learning based to improve detection of transthyretin cardiac amyloidosis: the R3M algorithm

Session: Myocardial disease - hypertrophic cardiomyopathy 3

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor A. Fraix (Nancy, FR)

Event: Heart Failure 2023

Congress Presentation

About the speaker

Doctor Antoine Fraix

University Hospital of Brabois , Nancy (France)

0 follower

6 more presentations in this session

Patient-reported outcome measures in wild-type and variant cardiac transthyretin amyloidosis: the ITALY (impact of transthyretin amyloidosis on life quality) study

Speaker: Doctor A. Aimo (Pisa, IT)

Hypertrophic cardiomyopathy in female patients is associated with symptomatic heart failure and worse functional and exercise capacity

Speaker: Doctor Y. Wasserstrum (Ramat Gan, IL)

Estimation of the target population of a selective cardiac myosin inhibitor for hypertrophic obstructive cardiomyopathy: Real-life data from the French REMY register.

Speaker: Doctor T. Muresan (Paris, FR)

Relative apical longitudinal strain: a powerful tool to predict outcomes in transthyretin amyloid cardiomyopathy

Speaker: Doctor M. Castro (Guimaraes, PT)

A novel myocardium functional echocardiographic parameter, left ventricular myocardial work, associates with sudden cardiac risk score in patients with hypertrophic cardiomyopathy

Speaker: Doctor G. Racz (Szeged, HU)

Access the full session

Myocardial disease - hypertrophic cardiomyopathy 3

Speakers: Doctor A. Fraix, Doctor A. Aimo, Doctor Y. Wasserstrum, Doctor T. Muresan, Doctor M. Castro...

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by